American Heart Journal
Volume 147, Issue 6 , Pages 948-949 , June 2004

Secondary prevention after coronary artery bypass graft: a primary issue?

  • T.Bruce Ferguson Jr, MD

      Affiliations

    • Departments of Surgery and Physiology, LSUSHC, New Orleans, La, USA
    • Corresponding Author InformationReprint requests: T. Bruce Ferguson, Jr., MD, LSUSHC Cardiovascular Outcomes Research Group, 3535 Bienville Street, Suite E-325, New Orleans, LA 70119, USA.

References 

  1. Favaloro RG. Critical analysis of coronary artery bypass surgery (a 30-year journey). J Am Coll Cardiol. 1998;31:1–63B
  2. Mack MJ. Beating heart surgery (does it make a difference?). Am Heart Hosp J. 2003;1:149–157
  3. Loop FD, Lytle BD, Cosgrove DM, et al.  Influence of the internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1–6
  4. Ferguson TB, Hammill B, Peterson ED, et al.  A decade of change (risk profiles and outcomes for isolated CABG procedures, 1990-1999). Ann Thorac Surg. 2002;73:480–490
  5. Bradshaw PJ, Jamrozik K, Gilfillan I, et al. Preventing recurrent events long-term after coronary artery bypass: suboptimal use of medications in a population study. Am Heart J 2004;147:1047–53
  6. Greenland P, Knoll MD, Stamler J, et al.  Major risk factors as antecedents of fatal and non-fatal coronary heart disease events. JAMA. 2003;290:891–897
  7. Khot UN, Khot MB, Bajzer CT, et al.  Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290:898–904
  8. Goldman S, Copeland J, Moritz T, et al.  Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of anti-platelet therapy (results of a Veterans Administration Cooperative Study). Circulation. 1989;80:1190–1197
  9. Knatterud GL, Rosenberg Y, Campeau L, et al.  Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post-coronary artery bypass graft trial. Circulation. 2000;102:157–165
  10. Eagle KA, Guyton RA, Davidoff R, et al.  ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery (executive summary and recommendations). Circulation. 1999;100:1464–1480
  11. Gibbon RJ, Abrams J, Chatterjee K, et al.  ACC/AHA 2002 Guideline Update for the management of patients with chronic stable angina (summary article). Circulation. 2003;107:149–158
  12. Holman WL, Allman RM, Sansom M, et al.  Alabama Coronary Artery Bypass Grafting (CABG) Project (results of a state-wide quality improvement initiative). JAMA. 2001;285:3003–3010
  13. O'Connor GT, Plume SK, Olmstead EM, et al.  A regional intervention to improve the hospital mortality associated with coronary artery bypass graft surgery (the Northern New England Cardiovascular Disease Study Group). JAMA. 1996;275:841–846
  14. Ferguson TB, Peterson ED, Coombs LP, et al.  Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery (a randomized controlled trial). JAMA. 2003;290:49–56

PII: S0002-8703(04)00016-X

doi: 10.1016/j.ahj.2003.12.024

American Heart Journal
Volume 147, Issue 6 , Pages 948-949 , June 2004

Article Tools